Feasibility and Safety of Single-Port Robotic-Assisted Deep Inferior Epigastric Pedicle Flap Harvest ((DIEP))

May 23, 2026 updated by: Galen Perdikis, Vanderbilt University Medical Center

Feasibility and Safety of Single-Port Robotic-Assisted DIEP Flap Harvest for Breast Reconstruction: A Prospective Evaluation

The primary aim of this study is to evaluate the feasibility of single-port robotic surgery for DIEP flap breast reconstruction. The investigators will also investigate complications of the procedure, incision length, flap success rate, post operative pain, vascular pedicle length and caliber, and VMP-B score (quality of life/satisfaction of breast procedures survey).

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This project will be conducted at Vanderbilt University Medical Center. Patients scheduled for a DIEP flap procedure will be recruited through screening of the electronic medical records (EMR) to evaluate eligibility based on pre-established inclusion and exclusion criteria. Eligible patients will be invited to participate in a preoperative consultation, during which they will receive detailed information about the study, including the surgical techniques, potential risks, and benefits. Written informed consent will be obtained from those who agree to participate.

Baseline data available in the medical records as part of their clinical care, including patient demographics, medical history, imaging, pictures, pain and quality-of-life metrics, will also be collected.

On the day of surgery, patients will undergo standard preoperative preparations. The procedure will involve robotic-assisted DIEP flap harvest using single-port access, followed by flap transfer and microsurgical anastomosis. Post-surgical donor site closure will employ techniques to minimize morbidity. Key intraoperative data, such as operative time and complications, will be recorded.

Patient Electronic Medical Records (EMR) will be accessed by research personnel to monitor patients who elect to have the proposed procedure. Postoperative monitoring will focus on flap viability and patient recovery during the hospital stay and subsequent follow-ups. Assessments will include complications, donor site integrity, pain levels, and patient-reported outcomes. Follow-up visits will evaluate both short- and long-term outcomes, including satisfaction and quality of life, providing comprehensive data for the study's primary and secondary aims.

Study Type

Interventional

Enrollment (Estimated)

4

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Recruiting
        • Vanderbilt University Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Female patients aged ≥18 years.
  • Candidates for unilateral or bilateral breast reconstruction using a DIEP flap.
  • No contraindications for general anesthesia or robotic surgery.
  • Patients with adequate abdominal donor tissue for DIEP flap harvest.

Exclusion Criteria:

  • History of prior abdominal surgery that significantly compromises perforator vessel integrity.
  • Pregnant woman.
  • Prisoners.
  • BMI > 35, as measured during the preoperative evaluation.
  • Presence of comorbidities that contraindicate elective surgery.
  • Active cancer other than breast cancer at the time of evaluation.
  • Active metastatic disease confirmed via imaging or biopsy.
  • Inability to comply with follow-up visits.
  • The research team decides to exclude the patient.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robotic Assisted DIEP Breast Reconstruction
This group consists of patients receiving the investigative procedure - robotic assisted DIEP flap harvest for breast reconstruction.
Utilizing the Single-Port robotic system for DIEP flap harvest has been previously described, but only in a small pilot study. The investigators plan to demonstrate the feasibility and safety of this approach on a larger cohort of patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of performing DIEP flap breast construction using a single port robotic system
Time Frame: From enrollment to the end of the procedure.
This will be "Yes" if the following are true of the procedure: completed pedicle dissection using the robotic system, adequate pedicle dissected, and no intraoperative complication requiring conversion to the open approach.
From enrollment to the end of the procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication Rates
Time Frame: Through study completion, an average of 1 year.
Intraoperative and postoperative complications. Including, but not limited to: flap failure, internal structure injuries, deep venous thrombosis, etc.
Through study completion, an average of 1 year.
Fascial Incision Length
Time Frame: Through study completion, an average of 1 year.
Measurement of the fascial incision length and prevalence of abdominal herniation or bulging through the incision.
Through study completion, an average of 1 year.
Flap Success Rate
Time Frame: From procedure to 7 days post operation.
We define flap success rate as survival of the flap without loss of viability through a specified time window.
From procedure to 7 days post operation.
Operative Time
Time Frame: From procedure start to procedure completion.
The time interval between first skin incision to skin closure of the patient.
From procedure start to procedure completion.
Pain Level
Time Frame: From procedure to postoperative day (POD) 1, 2, 3, 7, 14, and 30.
The patient level of pain on a scale of 1 (no pain) to 10 (extreme pain).
From procedure to postoperative day (POD) 1, 2, 3, 7, 14, and 30.
Vascular Pedicle Length
Time Frame: During the operative procedure (approximately 6 - 10 hours, intraoperative measurement)
The pedicle length used for anastomosis will be measured intraoperatively, reported in mm.
During the operative procedure (approximately 6 - 10 hours, intraoperative measurement)
Vanderbilt Mini Patient Reported Outcome - Breast (VMP-B) Score
Time Frame: From enrollment to 12 months post operation. Surveys will be distributed preoperatively and at postoperative follow up intervals (2 weeks, 6 weeks, 3 months, 6 months, and 12 months).
The investigators will collect patient VMP-B (a validated patient reported outcome) scores to assess patient well being and satisfaction with their procedure. Items (16 total) are scored on a 5-point Likert scale, scores range from 16 (worst) to 80 (best).
From enrollment to 12 months post operation. Surveys will be distributed preoperatively and at postoperative follow up intervals (2 weeks, 6 weeks, 3 months, 6 months, and 12 months).
Pain Management
Time Frame: From procedure to postoperative day (POD) 1, 2, 3, 7, 14, and 30.
The investigators will record what analgesics are used to control patient pain.
From procedure to postoperative day (POD) 1, 2, 3, 7, 14, and 30.
Vascular Pedicle Caliber
Time Frame: During the operative procedure (approximately 6 - 10 hours, intraoperative measurement)
The pedicle caliber used for anastomosis will be measured intraoperatively, reported in mm.
During the operative procedure (approximately 6 - 10 hours, intraoperative measurement)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Galen Perdiks, MD, Vanderbilt University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

September 9, 2025

First Submitted That Met QC Criteria

October 27, 2025

First Posted (Actual)

October 30, 2025

Study Record Updates

Last Update Posted (Actual)

May 27, 2026

Last Update Submitted That Met QC Criteria

May 23, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

As this is a feasibility study - there is no indication to share individual participant data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on DIEP Flap Breast Reconstruction

Clinical Trials on Single-Port Robotic System

Subscribe